×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Allergy Immunotherapy Market

ID: MRFR/HC/54530-HCR
200 Pages
MRFR Team
June 2025

South America Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies), By Patient Type (Pediatric, Adult, Geriatric) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

South America Allergy Immunotherapy Market Summary

Industry Developments

The South America Allergy Immunotherapy Market has recently seen significant developments, influenced by companies such as Stallergenes Greer, Anergis, ImmunoCap, Aimmune Therapeutics, Boehringer Ingelheim, Thermo Fisher Scientific, Mylan, Novartis, ALK Technologies, Merck KGaA, HollisterStier Allergy, Datapharm, and Alk Abello. In May 2023, Stallergenes Greer announced an expansion of its operations in Brazil to enhance its production and distribution capabilities. Additionally, in August 2023, Boehringer Ingelheim launched a new line of allergy immunotherapy products in Argentina, responding to the rising prevalence of allergic conditions in the region. Over the past two years, the market has also witnessed growth, attributed to increased investments and collaborations among the key players. For instance, Aimmune Therapeutics and Merck KGaA revealed a partnership in early 2022 aimed at advancing Research and Development for allergic food therapies in Brazil. The Allergy Immunotherapy Market is projected to expand due to rising awareness of allergies and overall healthcare investment in South America. These developments are indicative of the dynamic and evolving landscape of the allergy treatment sector across the continent.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 2018532.0(USD Million)
MARKET SIZE 2024571.0(USD Million)
MARKET SIZE 20351250.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.383% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDStallergenes Greer, Anergis, ImmunoCap, Aimmune Therapeutics, Boehringer Ingelheim, Thermo Fisher Scientific, Mylan, Novartis, ALK Technologies, Merck KGaA, HollisterStier Allergy, Datapharm, Alk Abello
SEGMENTS COVEREDType, Product, Indication, Patient Type, Regional
KEY MARKET OPPORTUNITIESRising prevalence of allergies, Increasing awareness of immunotherapy, Growing investment in healthcare, Innovative treatment options emerging, Expansion of distribution networks
KEY MARKET DYNAMICSincreasing allergic conditions prevalence, growing awareness of immunotherapy, advancements in treatment technologies, supportive regulatory environment, rising healthcare expenditure
COUNTRIES COVEREDBrazil, Mexico, Argentina, Rest of South America

Leave a Comment

FAQs

What is the projected market size of the South America Allergy Immunotherapy Market by 2035?

The South America Allergy Immunotherapy Market is projected to reach a valuation of 1250.0 USD Million by 2035.

What is the expected CAGR for the South America Allergy Immunotherapy Market from 2025 to 2035?

The market is expected to grow at a CAGR of 7.383% from 2025 to 2035.

Which region holds the largest share in the South America Allergy Immunotherapy Market?

Brazil holds the largest market share, valued at 245.0 USD Million in 2024.

What is the market size for Subcutaneous Immunotherapy in 2024?

Subcutaneous Immunotherapy is valued at 230.0 USD Million in 2024.

Who are the major players in the South America Allergy Immunotherapy Market?

Major players include Stallergenes Greer, Anergis, ImmunoCap, and Boehringer Ingelheim.

How much is the market size for Sublingual Immunotherapy expected to be in 2035?

Sublingual Immunotherapy is expected to reach a market size of 450.0 USD Million by 2035.

What is the projected market size for Oral Immunotherapy by 2035?

Oral Immunotherapy is projected to be valued at 300.0 USD Million by 2035.

How is the South America Allergy Immunotherapy Market segmented by region?

The market is segmented into Brazil, Mexico, Argentina, and the Rest of South America.

What is the expected market size for Mexico in 2024?

Mexico is expected to account for 150.0 USD Million in the Allergy Immunotherapy Market in 2024.

What challenges could impact the growth of the South America Allergy Immunotherapy Market?

Challenges may include regulatory hurdles and varying healthcare access across regions.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions